Pepsin-mediated inflammation in laryngopharyngeal reflux via the ROS/NLRP3/IL-1β signaling pathway

This publication has 37 references indexed in Scilit:

• Association of pepsin and DNA damage in laryngopharyngeal reflux-related vocal fold polyps
  American Journal of Otolaryngology, 2020
• Proton Pump Inhibitors for the Treatment of Laryngopharyngeal Reflux. A Systematic Review
  Journal of Voice, 2020
• An epidemiological survey of laryngopharyngeal reflux disease at the otorhinolaryngology-head and neck surgery clinics in China
  European Archives of Oto-Rhino-Laryngology, 2020
• Cigarette smoke induces the pyroptosis of urothelial cells through ROS/NLRP3/caspase‐1 signaling pathway
  Neurourology and Urodynamics, 2020
• Gastroesophageal reflux in laryngopharyngeal reflux patients: Clinical features and therapeutic response
  The Laryngoscope, 2019
• A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2α: a potential role for targeting HIF-2α to prevent and treat reflux esophagitis
  Current Opinion in Pharmacology, 2017
• Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes
  JAMA, 2016
• O 2 sensing, mitochondria and ROS signaling: The fog is lifting
  Molecular Aspects of Medicine, 2016
• Laryngeal mucosa: Its susceptibility to damage by acid and pepsin
  The Laryngoscope, 2010
• Pepsin as a causal agent of inflammation during nonacidic reflux
  Otolaryngology–Head and Neck Surgery, 2009